TRAINING ARTICLE
Fierce Pharma
NOVEMBER 27, 2023
THIS IS WHERE THE TEXT OF THE ARTICLE WILL BE. | The introduction that will be displayed in the newsletter.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Fierce Pharma
NOVEMBER 27, 2023
THIS IS WHERE THE TEXT OF THE ARTICLE WILL BE. | The introduction that will be displayed in the newsletter.
Fierce Pharma
JANUARY 6, 2024
A group of cell therapy experts, including CAR-T pioneers Drs. Bruce Levine and Carl June, wrote in support of continued use of CAR-T therapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 12, 2024
Journal retracts three articles on MDMA-assisted psychotherapy, shortly after FDA blocks approval of @Lykos_PBC's therapy for PTSD
Fierce Pharma
JANUARY 4, 2024
Article by Richard Pops, CEO of Alkermes | Alkermes, a pioneer in neuroscience therapeutics, is building on its foundation as it emerges as a pure neuroscience company.
Eversana Intouch
DECEMBER 1, 2023
Recently, Ad Forum published an article highlighting five campaigns it found to be “ Raising the Bar for Health Equity in Advertising.” And, you can read the Ad Forum article here ! One was our ongoing work with The Chrysalis Initiative, a nonprofit working to eliminate racial disparities in breast cancer treatment.
Pharmaceutical Commerce
APRIL 8, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features.
PharmaVoice
DECEMBER 20, 2024
The high drama of an election year, industry layoffs, patent cliff strategies and other key trends that shaped pharma in 2024.
World of DTC Marketing
FEBRUARY 15, 2022
Finally, having your CEO write articles for business publications is a good idea. The articles should not be self-promotional but instead, talk about the disease state and issues facing small biotech companies. One biotech had to lay off over 100 people because of a setback with the FDA. Hire people as you need them, not before.
Copyright Clearance Center
NOVEMBER 7, 2022
November 7, 2022, LEHI, Utah — CloudSource+ , the newest content solution for open access materials from SirsiDynix , has integrated with Get It Now from CCC (Copyright Clearance Center) to provide immediate purchase and delivery of full-text articles to unsubscribed journals. Stay within budget with advanced data and reporting.
Pharma IQ
APRIL 29, 2024
In this insightful article, Tim O’Connor, Chief Data Scientist at Phenomix Sciences, discusses the pivotal role. Discover how artificial intelligence is revolutionizing the field of precision medicine.
Clarivate
FEBRUARY 9, 2023
We’ve created the Preprint Citation Index so researchers can discover and use both preprints and journal articles, on one trusted platform. We are linking preprints and the scholarly articles they cite, so researchers can find the latest research relating to an article. This link does not display a numerical citation count.
MedCity News
NOVEMBER 22, 2022
Based on some independent research that my company commissioned with more than 200 companies, we came to several conclusions that are highlighted in the article. Broadly, however, it signals the false sense of (cyber)security that many companies are currently harboring.
European Pharmaceutical Review
JANUARY 2, 2024
To continue bridging the gaps between traditional and modern (enhanced) development approaches, the industry should attend regulatory expectations and pursue innovative frameworks that guarantee high-quality levels,” Simões et al. concluded.
David Bagga
JUNE 15, 2024
This article will […] The post Top 10 Medical Sales Training Programs To Grow Your Career appeared first on. Medical Device Sales Academy Top 10 Medical Sales Training Programs To Grow Your Career Following a career in medical sales can be both challenging and rewarding.
MedCity News
NOVEMBER 3, 2023
This article delves into the importance of audience segmentation, offers guidance on identifying distinct audience groups, and discusses influential personas in healthcare.
PharmaTech
OCTOBER 23, 2024
This article presents an overview of FDA’s recent update to the guidance document, Control of Nitrosamine Impurities in Human Drugs.
Eversana Intouch
MARCH 15, 2024
In a recent article published by Med Ad News and PharmaLive.com , Hattie Stearns, Senior Director of Experience DesignOps, provides five key takeaways she observed as a brand and design lead at SXSW 2024.
MedCity News
AUGUST 26, 2022
By adopting the measures identified in this article, healthcare organizations can help to improve their cybersecurity and mitigate risk. The healthcare industry is under constant threat from cyberattacks.
Pharmaceutical Commerce
JANUARY 9, 2024
Review article explores the latest developments surrounding expression and purification strategies.
World of DTC Marketing
JULY 9, 2021
This week an article entitles dais that Pfizer’s and Moderna’s vaccines could be seeing a “worst-case scenario.” Hours after Pfizer issued its statement, the FDA and Centers for Disease and Control issued a joint statement saying Americans do not need booster shots yet” So who to believe?
MedCity News
DECEMBER 27, 2023
While it may appear that hospital administrators and biotech CEOs have quite dissimilar jobs because they face different challenges daily, this article attempts to conveys the value of some of the underlying principles that one can develop in the field of hospital administration, that may have some value in other healthcare fields and in other executive (..)
MedCity News
APRIL 2, 2024
This article addresses five common misconceptions about immersive VR simulations. There are some lingering misconceptions around the use of VR that are likely to give instructors pause when considering whether to add a VR component to the nursing curriculum.
MedCity News
FEBRUARY 14, 2023
Some providers are still hesitant about certain technology advancements, but this article shows not only how critical tech will be to the healthcare industry at large, but also how it can help to lessen the toll of unpredictable crises, like the pandemic or the insurmountable nursing shortage we’re currently facing.
MedCity News
JUNE 6, 2024
In this article, he explains three steps hospitals can take to actually boost accessibility. The post Providers Should Do These 3 Things to Improve Access appeared first on MedCity News.
MedCity News
SEPTEMBER 21, 2023
This article explores the benefits of implementing RFID in healthcare settings and how hospitals can gradually transition from barcode to RFID-enabled medication systems, leading to substantial cost savings and improved patient care.
PharmaTech
JANUARY 31, 2024
This article introduces that the basic technique for tolerance interval is implemented using the conventional range 85–115% LC where the proposed range in the PF is not taken into account.
MedCity News
OCTOBER 23, 2024
In a series of articles to promote INVEST 2025 in Chicago April 29-30, we are highlighting investment insights and perspectives in the runup to the boutique event for traditional and strategic healthcare investors and startups. Register today!
Eversana Intouch
APRIL 4, 2024
In the article , Elizabeth Rooney, Executive Creative Director, EVERSANA INTOUCH, explains the strategy behind the new TV spots. Read the full MM+M article and watch the spots here. It’s estimated that some 85% of TD cases go undiagnosed. I feel like this campaign infuses a sense of optimism and opportunity.”
Medical Device Success
AUGUST 14, 2022
Dr. Ali is working with SAGES to write an article to better define and classify this important subject. Dr. Ali is working with SAGES to write an article to better define and classify this important subject. What does this mean and what are these pillars? To help us with this is Jawad Ali, MD, a surgeon and community builder.
European Pharmaceutical Review
NOVEMBER 26, 2024
The article, titled ‘Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials’ was published in the journal The Lancet Diabetes & Endocrinology. Fatalities by any cause was 13 percent less in individuals given GLP-1 receptor agonists, the analysis showed.
World of DTC Marketing
JUNE 27, 2021
Novo’s PR department did a great job and most articles about the drug did talk about the side effects but how many people really read that deep? In researching research trends, Wegovy.com doesn’t have much traffic at all, but the DTC for the product has not started yet.
Eversana Intouch
JULY 9, 2024
As Brent Scholz, SVP, Executive Creative Director at EVERSANA INTOUCH, aptly states in the article , “There’s no proprietary blueprint for rare disease campaigns.” Read the full MM+M article here. In the realm of rare disease awareness, medical marketers must employ creative and nuanced strategies.
MedCity News
AUGUST 3, 2023
I am a practicing UK general practitioner and in this article, I take a magnifying glass to quality indicators including access, affordability, healthcare inequalities and population health, staffing and equipment, and patient and provider experience to discuss how we can shape up.
pharmaphorum
NOVEMBER 5, 2024
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest market, wiping around $14 billion off its value.The sell-off appears to have been prompted by an article in Chinese financial media outlet Yicai which suggested that "dozens of senior executives" at AZ's Chinese subsidiary have been (..)
Eversana Intouch
AUGUST 25, 2023
” In a recent article for PharmaLive.com and Med Ad News, Elizabeth Rooney, Managing Director, Executive Creative Director, EVERSANA INTOUCH urges all healthcare marketers to make the most of this moment in the cultural zeitgeist to make a difference for women’s health. How can we, as pharma marketers, keep the momentum going?”
Copyright Clearance Center
JANUARY 9, 2024
. – CCC , a pioneer in voluntary collective licensing with the mission of advancing copyright, accelerating knowledge, and powering innovation, announces that RightFind XML , the company’s scientific article discovery solution, was chosen as the Bio-IT World 2023 Best in Show award honoree at its World Conference & Expo Europe in London.
World of DTC Marketing
NOVEMBER 4, 2020
The top 50 articles garnered more than 12 million shares, comments, and reactions this year, mostly on Facebook. Fighting Online Health Misinformation.
World of DTC Marketing
OCTOBER 2, 2021
I wanted to reach out to each one and send links to articles on treatments I found in various medical journals. We’re not in the business of selling; we’re in the business of helping patients chose the proper treatment. As I read the comments from patients and caregivers, I felt a deep sense of empathy.
World of DTC Marketing
MARCH 24, 2022
When he sent some journal articles to the salesforce without first getting approval from legal and regulatory, he got in trouble, but it wasn’t enough to replace him. John worked for a division of a major pharma company in Cambridge. He came from the salesforce, and his mentality was simple; marketing supports sales.
World of DTC Marketing
NOVEMBER 11, 2020
The top 50 articles garnered more than 12 million shares, comments, and reactions this year, mostly on Facebook” Despite the rise in online health seekers, pharma is not part of the solution to combat fake health news.
World of DTC Marketing
AUGUST 16, 2022
A New York Times article said, “Poor diet is the leading cause of mortality in the U.S.” He railed on body positivity, saying there’s a movement in America to rewrite science to fit ideology, adding “fat is now celebrated.”He’s ”He’s right. We’ve gone from fat acceptance to fat celebration.
European Pharmaceutical Review
NOVEMBER 9, 2023
Impact of the AMR certification Following the launch of the certification programme’s in June 2023, a range of antibiotic products have successfully completed the certification process within each of the organisations, BSI confirmed.
Copyright Clearance Center
JULY 18, 2023
The conversations resulted in CCC’s adoption of the European Statistical Advisory Committee (ESAC) Article List, an OA agreement reporting template which has become a powerful reference for data sharing practices in support of the move to OA.
PM360
NOVEMBER 27, 2023
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the U.S. In this article, we investigate strategies that manufacturers could consider to optimize pricing and access opportunities for their combinations in today’s environment. and Europe.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content